Global Equine Rhinopneumonitis Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis?viruses that are prevalent in horses and can cause outbreaks of respiratory disease.
LPI (LP Information)' newest research report, the “Equine Rhinopneumonitis Vaccine Industry Forecast” looks at past sales and reviews total world Equine Rhinopneumonitis Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Equine Rhinopneumonitis Vaccine sales for 2023 through 2029. With Equine Rhinopneumonitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Rhinopneumonitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Equine Rhinopneumonitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Rhinopneumonitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Equine Rhinopneumonitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Rhinopneumonitis Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Rhinopneumonitis Vaccine.
The global Equine Rhinopneumonitis Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Equine Rhinopneumonitis Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Equine Rhinopneumonitis Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Equine Rhinopneumonitis Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Equine Rhinopneumonitis Vaccine players cover Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim, Santa Cruz Animal Health and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Rhinopneumonitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Equine Rhinopneumonitis Vaccine market?
What factors are driving Equine Rhinopneumonitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Rhinopneumonitis Vaccine market opportunities vary by end market size?
How does Equine Rhinopneumonitis Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Equine Rhinopneumonitis Vaccine can prevent Equine Rhinopneumonitis?viruses that are prevalent in horses and can cause outbreaks of respiratory disease.
LPI (LP Information)' newest research report, the “Equine Rhinopneumonitis Vaccine Industry Forecast” looks at past sales and reviews total world Equine Rhinopneumonitis Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Equine Rhinopneumonitis Vaccine sales for 2023 through 2029. With Equine Rhinopneumonitis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Equine Rhinopneumonitis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Equine Rhinopneumonitis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Equine Rhinopneumonitis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Equine Rhinopneumonitis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Equine Rhinopneumonitis Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Equine Rhinopneumonitis Vaccine.
The global Equine Rhinopneumonitis Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Equine Rhinopneumonitis Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Equine Rhinopneumonitis Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Equine Rhinopneumonitis Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Equine Rhinopneumonitis Vaccine players cover Zoetis, Nisseiken Co., Ltd., Boehringer Ingelheim, Santa Cruz Animal Health and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Equine Rhinopneumonitis Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Live
- Inactivated
- Veterinary Pharmacy
- Online Sale
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Nisseiken Co., Ltd.
- Boehringer Ingelheim
- Santa Cruz Animal Health
- Merck
What is the 10-year outlook for the global Equine Rhinopneumonitis Vaccine market?
What factors are driving Equine Rhinopneumonitis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Equine Rhinopneumonitis Vaccine market opportunities vary by end market size?
How does Equine Rhinopneumonitis Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Rhinopneumonitis Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Equine Rhinopneumonitis Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Equine Rhinopneumonitis Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Equine Rhinopneumonitis Vaccine Segment by Type
2.2.1 Live
2.2.2 Inactivated
2.3 Equine Rhinopneumonitis Vaccine Sales by Type
2.3.1 Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Equine Rhinopneumonitis Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Equine Rhinopneumonitis Vaccine Sale Price by Type (2018-2023)
2.4 Equine Rhinopneumonitis Vaccine Segment by Application
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Equine Rhinopneumonitis Vaccine Sales by Application
2.5.1 Global Equine Rhinopneumonitis Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Equine Rhinopneumonitis Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Equine Rhinopneumonitis Vaccine Sale Price by Application (2018-2023)
3 GLOBAL EQUINE RHINOPNEUMONITIS VACCINE BY COMPANY
3.1 Global Equine Rhinopneumonitis Vaccine Breakdown Data by Company
3.1.1 Global Equine Rhinopneumonitis Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Equine Rhinopneumonitis Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Equine Rhinopneumonitis Vaccine Revenue by Company (2018-2023)
3.2.2 Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Equine Rhinopneumonitis Vaccine Sale Price by Company
3.4 Key Manufacturers Equine Rhinopneumonitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Rhinopneumonitis Vaccine Product Location Distribution
3.4.2 Players Equine Rhinopneumonitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EQUINE RHINOPNEUMONITIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Equine Rhinopneumonitis Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Equine Rhinopneumonitis Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Equine Rhinopneumonitis Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Equine Rhinopneumonitis Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Equine Rhinopneumonitis Vaccine Sales Growth
4.4 APAC Equine Rhinopneumonitis Vaccine Sales Growth
4.5 Europe Equine Rhinopneumonitis Vaccine Sales Growth
4.6 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Equine Rhinopneumonitis Vaccine Sales by Country
5.1.1 Americas Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023)
5.1.2 Americas Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023)
5.2 Americas Equine Rhinopneumonitis Vaccine Sales by Type
5.3 Americas Equine Rhinopneumonitis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Rhinopneumonitis Vaccine Sales by Region
6.1.1 APAC Equine Rhinopneumonitis Vaccine Sales by Region (2018-2023)
6.1.2 APAC Equine Rhinopneumonitis Vaccine Revenue by Region (2018-2023)
6.2 APAC Equine Rhinopneumonitis Vaccine Sales by Type
6.3 APAC Equine Rhinopneumonitis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Rhinopneumonitis Vaccine by Country
7.1.1 Europe Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023)
7.1.2 Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023)
7.2 Europe Equine Rhinopneumonitis Vaccine Sales by Type
7.3 Europe Equine Rhinopneumonitis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Rhinopneumonitis Vaccine by Country
8.1.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type
8.3 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Rhinopneumonitis Vaccine
10.3 Manufacturing Process Analysis of Equine Rhinopneumonitis Vaccine
10.4 Industry Chain Structure of Equine Rhinopneumonitis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Rhinopneumonitis Vaccine Distributors
11.3 Equine Rhinopneumonitis Vaccine Customer
12 WORLD FORECAST REVIEW FOR EQUINE RHINOPNEUMONITIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Equine Rhinopneumonitis Vaccine Market Size Forecast by Region
12.1.1 Global Equine Rhinopneumonitis Vaccine Forecast by Region (2024-2029)
12.1.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Equine Rhinopneumonitis Vaccine Forecast by Type
12.7 Global Equine Rhinopneumonitis Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Nisseiken Co., Ltd.
13.2.1 Nisseiken Co., Ltd. Company Information
13.2.2 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nisseiken Co., Ltd. Main Business Overview
13.2.5 Nisseiken Co., Ltd. Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Santa Cruz Animal Health
13.4.1 Santa Cruz Animal Health Company Information
13.4.2 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Santa Cruz Animal Health Main Business Overview
13.4.5 Santa Cruz Animal Health Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.5.3 Merck Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Equine Rhinopneumonitis Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Equine Rhinopneumonitis Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Equine Rhinopneumonitis Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Equine Rhinopneumonitis Vaccine Segment by Type
2.2.1 Live
2.2.2 Inactivated
2.3 Equine Rhinopneumonitis Vaccine Sales by Type
2.3.1 Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Equine Rhinopneumonitis Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Equine Rhinopneumonitis Vaccine Sale Price by Type (2018-2023)
2.4 Equine Rhinopneumonitis Vaccine Segment by Application
2.4.1 Veterinary Pharmacy
2.4.2 Online Sale
2.4.3 Others
2.5 Equine Rhinopneumonitis Vaccine Sales by Application
2.5.1 Global Equine Rhinopneumonitis Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Equine Rhinopneumonitis Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Equine Rhinopneumonitis Vaccine Sale Price by Application (2018-2023)
3 GLOBAL EQUINE RHINOPNEUMONITIS VACCINE BY COMPANY
3.1 Global Equine Rhinopneumonitis Vaccine Breakdown Data by Company
3.1.1 Global Equine Rhinopneumonitis Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Equine Rhinopneumonitis Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Equine Rhinopneumonitis Vaccine Revenue by Company (2018-2023)
3.2.2 Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Equine Rhinopneumonitis Vaccine Sale Price by Company
3.4 Key Manufacturers Equine Rhinopneumonitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Equine Rhinopneumonitis Vaccine Product Location Distribution
3.4.2 Players Equine Rhinopneumonitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR EQUINE RHINOPNEUMONITIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Equine Rhinopneumonitis Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Equine Rhinopneumonitis Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Equine Rhinopneumonitis Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Equine Rhinopneumonitis Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Equine Rhinopneumonitis Vaccine Sales Growth
4.4 APAC Equine Rhinopneumonitis Vaccine Sales Growth
4.5 Europe Equine Rhinopneumonitis Vaccine Sales Growth
4.6 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Equine Rhinopneumonitis Vaccine Sales by Country
5.1.1 Americas Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023)
5.1.2 Americas Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023)
5.2 Americas Equine Rhinopneumonitis Vaccine Sales by Type
5.3 Americas Equine Rhinopneumonitis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Equine Rhinopneumonitis Vaccine Sales by Region
6.1.1 APAC Equine Rhinopneumonitis Vaccine Sales by Region (2018-2023)
6.1.2 APAC Equine Rhinopneumonitis Vaccine Revenue by Region (2018-2023)
6.2 APAC Equine Rhinopneumonitis Vaccine Sales by Type
6.3 APAC Equine Rhinopneumonitis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Equine Rhinopneumonitis Vaccine by Country
7.1.1 Europe Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023)
7.1.2 Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023)
7.2 Europe Equine Rhinopneumonitis Vaccine Sales by Type
7.3 Europe Equine Rhinopneumonitis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Equine Rhinopneumonitis Vaccine by Country
8.1.1 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type
8.3 Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Equine Rhinopneumonitis Vaccine
10.3 Manufacturing Process Analysis of Equine Rhinopneumonitis Vaccine
10.4 Industry Chain Structure of Equine Rhinopneumonitis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Equine Rhinopneumonitis Vaccine Distributors
11.3 Equine Rhinopneumonitis Vaccine Customer
12 WORLD FORECAST REVIEW FOR EQUINE RHINOPNEUMONITIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Equine Rhinopneumonitis Vaccine Market Size Forecast by Region
12.1.1 Global Equine Rhinopneumonitis Vaccine Forecast by Region (2024-2029)
12.1.2 Global Equine Rhinopneumonitis Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Equine Rhinopneumonitis Vaccine Forecast by Type
12.7 Global Equine Rhinopneumonitis Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Nisseiken Co., Ltd.
13.2.1 Nisseiken Co., Ltd. Company Information
13.2.2 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.2.3 Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Nisseiken Co., Ltd. Main Business Overview
13.2.5 Nisseiken Co., Ltd. Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 Santa Cruz Animal Health
13.4.1 Santa Cruz Animal Health Company Information
13.4.2 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.4.3 Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Santa Cruz Animal Health Main Business Overview
13.4.5 Santa Cruz Animal Health Latest Developments
13.5 Merck
13.5.1 Merck Company Information
13.5.2 Merck Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
13.5.3 Merck Equine Rhinopneumonitis Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Merck Main Business Overview
13.5.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Equine Rhinopneumonitis Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Equine Rhinopneumonitis Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live
Table 4. Major Players of Inactivated
Table 5. Global Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Equine Rhinopneumonitis Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Equine Rhinopneumonitis Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Equine Rhinopneumonitis Vaccine Revenue by Application (2018-2023)
Table 13. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Equine Rhinopneumonitis Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Equine Rhinopneumonitis Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Equine Rhinopneumonitis Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Equine Rhinopneumonitis Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Equine Rhinopneumonitis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Equine Rhinopneumonitis Vaccine Products Offered
Table 22. Equine Rhinopneumonitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Equine Rhinopneumonitis Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Equine Rhinopneumonitis Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Equine Rhinopneumonitis Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Equine Rhinopneumonitis Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Equine Rhinopneumonitis Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Equine Rhinopneumonitis Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Equine Rhinopneumonitis Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Equine Rhinopneumonitis Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Equine Rhinopneumonitis Vaccine
Table 58. Key Market Challenges & Risks of Equine Rhinopneumonitis Vaccine
Table 59. Key Industry Trends of Equine Rhinopneumonitis Vaccine
Table 60. Equine Rhinopneumonitis Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Equine Rhinopneumonitis Vaccine Distributors List
Table 63. Equine Rhinopneumonitis Vaccine Customer List
Table 64. Global Equine Rhinopneumonitis Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Equine Rhinopneumonitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Equine Rhinopneumonitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Equine Rhinopneumonitis Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Equine Rhinopneumonitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Equine Rhinopneumonitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Equine Rhinopneumonitis Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Equine Rhinopneumonitis Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Equine Rhinopneumonitis Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Equine Rhinopneumonitis Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 80. Zoetis Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Nisseiken Co., Ltd. Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 85. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Nisseiken Co., Ltd. Main Business
Table 87. Nisseiken Co., Ltd. Latest Developments
Table 88. Boehringer Ingelheim Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Santa Cruz Animal Health Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 95. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Santa Cruz Animal Health Main Business
Table 97. Santa Cruz Animal Health Latest Developments
Table 98. Merck Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 100. Merck Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 1. Equine Rhinopneumonitis Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Equine Rhinopneumonitis Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live
Table 4. Major Players of Inactivated
Table 5. Global Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Equine Rhinopneumonitis Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Equine Rhinopneumonitis Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Equine Rhinopneumonitis Vaccine Revenue by Application (2018-2023)
Table 13. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Equine Rhinopneumonitis Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Equine Rhinopneumonitis Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Equine Rhinopneumonitis Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Equine Rhinopneumonitis Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Equine Rhinopneumonitis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Equine Rhinopneumonitis Vaccine Products Offered
Table 22. Equine Rhinopneumonitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Equine Rhinopneumonitis Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Equine Rhinopneumonitis Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Equine Rhinopneumonitis Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Equine Rhinopneumonitis Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Equine Rhinopneumonitis Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Equine Rhinopneumonitis Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Equine Rhinopneumonitis Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Equine Rhinopneumonitis Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Equine Rhinopneumonitis Vaccine
Table 58. Key Market Challenges & Risks of Equine Rhinopneumonitis Vaccine
Table 59. Key Industry Trends of Equine Rhinopneumonitis Vaccine
Table 60. Equine Rhinopneumonitis Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Equine Rhinopneumonitis Vaccine Distributors List
Table 63. Equine Rhinopneumonitis Vaccine Customer List
Table 64. Global Equine Rhinopneumonitis Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Equine Rhinopneumonitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Equine Rhinopneumonitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Equine Rhinopneumonitis Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Equine Rhinopneumonitis Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Equine Rhinopneumonitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Equine Rhinopneumonitis Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Equine Rhinopneumonitis Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Equine Rhinopneumonitis Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Equine Rhinopneumonitis Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Zoetis Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Zoetis Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 80. Zoetis Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Zoetis Main Business
Table 82. Zoetis Latest Developments
Table 83. Nisseiken Co., Ltd. Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 85. Nisseiken Co., Ltd. Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Nisseiken Co., Ltd. Main Business
Table 87. Nisseiken Co., Ltd. Latest Developments
Table 88. Boehringer Ingelheim Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 90. Boehringer Ingelheim Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Latest Developments
Table 93. Santa Cruz Animal Health Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 95. Santa Cruz Animal Health Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Santa Cruz Animal Health Main Business
Table 97. Santa Cruz Animal Health Latest Developments
Table 98. Merck Basic Information, Equine Rhinopneumonitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Equine Rhinopneumonitis Vaccine Product Portfolios and Specifications
Table 100. Merck Equine Rhinopneumonitis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
LIST OF FIGURES
Figure 1. Picture of Equine Rhinopneumonitis Vaccine
Figure 2. Equine Rhinopneumonitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Rhinopneumonitis Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Equine Rhinopneumonitis Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Equine Rhinopneumonitis Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Inactivated
Figure 11. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type in 2022
Figure 12. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Equine Rhinopneumonitis Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Equine Rhinopneumonitis Vaccine Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 15. Equine Rhinopneumonitis Vaccine Consumed in Online Sale
Figure 16. Global Equine Rhinopneumonitis Vaccine Market: Online Sale (2018-2023) & (K Units)
Figure 17. Equine Rhinopneumonitis Vaccine Consumed in Others
Figure 18. Global Equine Rhinopneumonitis Vaccine Market: Others (2018-2023) & (K Units)
Figure 19. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2022)
Figure 20. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Application in 2022
Figure 21. Equine Rhinopneumonitis Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Company in 2022
Figure 23. Equine Rhinopneumonitis Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Equine Rhinopneumonitis Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Equine Rhinopneumonitis Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Equine Rhinopneumonitis Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Equine Rhinopneumonitis Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Equine Rhinopneumonitis Vaccine
Figure 74. Industry Chain Structure of Equine Rhinopneumonitis Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Equine Rhinopneumonitis Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Equine Rhinopneumonitis Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Equine Rhinopneumonitis Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Equine Rhinopneumonitis Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Equine Rhinopneumonitis Vaccine
Figure 2. Equine Rhinopneumonitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Equine Rhinopneumonitis Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Equine Rhinopneumonitis Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Equine Rhinopneumonitis Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live
Figure 10. Product Picture of Inactivated
Figure 11. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Type in 2022
Figure 12. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Equine Rhinopneumonitis Vaccine Consumed in Veterinary Pharmacy
Figure 14. Global Equine Rhinopneumonitis Vaccine Market: Veterinary Pharmacy (2018-2023) & (K Units)
Figure 15. Equine Rhinopneumonitis Vaccine Consumed in Online Sale
Figure 16. Global Equine Rhinopneumonitis Vaccine Market: Online Sale (2018-2023) & (K Units)
Figure 17. Equine Rhinopneumonitis Vaccine Consumed in Others
Figure 18. Global Equine Rhinopneumonitis Vaccine Market: Others (2018-2023) & (K Units)
Figure 19. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2022)
Figure 20. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Application in 2022
Figure 21. Equine Rhinopneumonitis Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Company in 2022
Figure 23. Equine Rhinopneumonitis Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Equine Rhinopneumonitis Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Equine Rhinopneumonitis Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Equine Rhinopneumonitis Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Equine Rhinopneumonitis Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Equine Rhinopneumonitis Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Equine Rhinopneumonitis Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Equine Rhinopneumonitis Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Equine Rhinopneumonitis Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Equine Rhinopneumonitis Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Equine Rhinopneumonitis Vaccine
Figure 74. Industry Chain Structure of Equine Rhinopneumonitis Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Equine Rhinopneumonitis Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Equine Rhinopneumonitis Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Equine Rhinopneumonitis Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Equine Rhinopneumonitis Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Equine Rhinopneumonitis Vaccine Revenue Market Share Forecast by Application (2024-2029)
